Depression - Articles - Page 7

CARLAT WEBINAR

Treating Depression Collaboratively

April 21, 2023

0.50 CME Credits. Discover how primary care providers can effectively treat depression with the help of guidelines and algorithms, and learn when to refer patients to a psychiatrist in this informative webinar.

Research Update

An End to YAVIS Syndrome?

April 14, 2023

Sin Yan Lo, PMHNP-BC

Sin Yan Lo, PMHNP-BC. Ms. Lo has no financial relationships with companies related to this material.

A meta-analysis of psychotherapy in depression challenges conventional wisdom.

Research Update

Can Abstaining From Social Media Help People Feel Better?

April 14, 2023

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has no financial relationships with companies related to this material.

What happens when 154 volunteers are randomized to stay off the screen for a week?

Clinical Update

When Shorter Is Better

April 14, 2023

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Four scenarios where a time-limited approach to medication is ideal.

BOOK REVIEWS FOR PSYCHIATRISTS

A Review of A Mother's Reckoning

Stories that color-in the stark lines of evidence-based medicine.

April 13, 2023

Emily E. Whisler, DO and Edmund S. Higgins, MD.

Discover the emotional journey of a mother whose life was forever changed when she learned her son was involved in a crime.

Research Update

Why Do So Many Pediatric Antidepressant Research Trials “Fail”?

April 1, 2023

Pavan Madan, MD

Pavan Madan, MD. Dr. Madan has no financial relationships with companies related to this material.

Placebo response rates in antidepressant trials tend to run high, making it difficult to know whether an active medication has truly beneficial effect. This research update unpacks possible reasons for this phenomenon that give you insight into how to treat your patients using a rational multimodal approach.

Research Update

Stimulant Treatment Effect on Anxiety in ADHD

April 1, 2023

Gaurav Mishra, MD

Gaurav Mishra, MD. Dr. Mishra has no financial relationships with companies related to this material.

Are stimulant medication likely to exacerbate anxiety in ADHD kids? It’s reasonable concern, especially since mood symptoms can be worse with withdrawal and heart rate goes up in some kids on stimulants. This study gives nuanced insight into the degree to which stimulants impact anxiety in ADHD kids, for better and worse.

Expert Q&A

Addressing Suicidality in Autistic Children and Teens

April 1, 2023

Paul Lipkin, MD

Paul Lipkin, MD.

Neurodevelopmental and developmental behavioral pediatrician. Director, Medical Outpatient Services, Kennedy Krieger Institute, Baltimore, MD.

Dr. Lipkin has served as an advisor for EarliTec and Sarepta Diagnostics. Relevant financial relationships listed for the author have been mitigated.

Autistic kids and teens can become despondent or suicidal. When this happens, we need to take it as seriously as with anyone else. We interviewed Dr. Paul Lipkin who has truly useful tips to help us modify our assessment to communicate effectively back and forth to address the problem.

Expert Q&A

Management of Chronic Pain

April 1, 2023

Lewei (Allison) Lin, MD, MS

Lewei (Allison) Lin, MD, MS. Associate professor, Department of Psychiatry, University of Michigan Medical School; research scientist, Center for Clinical Management Research, VA Ann Arbor Healthcare System. Ann Arbor, MA.

Dr. Lin has served as a consultant for the National Committee for Quality Assurance via a grant from Alkermes. Relevant financial relationships listed for the author have been mitigated.

Patients with psychiatric conditions are more likely than other patients to experience chronic pain and to receive opioid prescriptions. Dr. Lin shares her holistic approaches to pain management that incorporate psychosocial, psychotherapeutic, and psychopharmacologic treatments.

Expert Q&A

Substance-Induced Depression: Diagnosis and Treatment

April 1, 2023

Bryan K. Tolliver, MD, PhD

Bryan K. Tolliver, MD, PhD

Associate professor, Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina. Charleston, SC.

Dr. Tolliver has no financial relationships with companies related to this material.

“When tailoring medication choice, a careful history can guide you. If I’m treating a patient who drinks excessively at night to sleep or who struggles with insomnia when they try to stop drinking, I’ll start with a sedating antidepressant like mirtazapine. That’s not an evidence-based decision, it’s a clinical decision that I think can be helpful.”

Dr. Tolliver gives us a framework to understand the relation between depression, substance use, and substance-induced mood disorders.